Skip to main content

Advertisement

SpringerLink
Log in

Ophthalmologic migraine

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

A fair portion of the diagnostic practice of the neurologist and ophthalmologist involves the deciphering of visual symptoms in patients known to have migraine, and many who at the time of their initial presentation do not. The most common visual disorder in this category, migraine with aura, has been studied extensively, but no conclusive evidence has been proven linking the visual aura, believed to result from a spreading depression, to the subsequent development of the cephalgia. Vasospasm remains controversial in the pathophysiology of migraine, but may play a role in patients who suffer more permanent or complicated neurovisual dysfunction. This paper reviews some of the current thoughts on the subject, and hopefully will stimulate the reader to explore the complex issue of this common malady.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gorji A: Spreading depression: a review of the clinical relevance. Brain Res Rev 2001, 38:33–60. A major review of the disorders associated with spreading depression.

    Article  PubMed  CAS  Google Scholar 

  2. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain. Cephalgia 1988, 8:1–96.

    Article  Google Scholar 

  3. Goadsby PJ, Lipton RB, Ferrari MD: Migraine—current understanding and treatment. N Engl J Med 2002, 346:257–270. Current summary of migraine pathophysiology.

    Article  PubMed  CAS  Google Scholar 

  4. Goadsby PJ: Pathophysiology of Headache. In Wolff’s Headache, edn 7. Edited by SD Silberstein, RB Lipton, DJ Delessio. New York: Oxford University Press; 2001:7–72.

    Google Scholar 

  5. Goadsby PJ: Migraine, aura, and cortical spreading depression: why are we still talking about it? Ann Neurol 2001, 49:4–6.

    Article  PubMed  CAS  Google Scholar 

  6. Spierings EL: Parallel concept of migraine pathogenesis [letter]. Ann Neurol 2001, 49:139–140.

    Article  Google Scholar 

  7. Goadsby PJ: Parallel concept of migraine pathogenesis [reply to letter]. Ann Neurol 2001, 49:140.

    Article  Google Scholar 

  8. Ebersberger A, Schaible HG, Averbeck B, et al.: Is there a correlation between spreading depression, neurogenic inflammation, and nociception that might cause migraine headache? Ann Neurol 2001, 49:7–13.

    Article  PubMed  CAS  Google Scholar 

  9. Mark AS, Casselman Brown D, et al.: Ophthalmoplegic migraine: reversible enhancement and thickening of the cisternal segment of the oculomotor nerve on contrastenhanced MR images. Am J Neuroradiol 1998, 19:1887–1891.

    PubMed  CAS  Google Scholar 

  10. Ramelli GP, Vella S, Lovblad K, et al.: Swelling of the third nerve in a child with transient oculomotor paresis: a possible cause of ophthalmoplegic migraine. Neuropediatrics 2000, 31:145–147.

    Article  PubMed  CAS  Google Scholar 

  11. Lance JW, Zagami AS: Ophthalmoplegic migraine: a recurrent demyelinating neuropathy. Cephalalgia 2001, 21:84–89.

    Article  PubMed  CAS  Google Scholar 

  12. Lee TG, Choi WS, Chung KC: Ophthalmoplegic migraine with reversible enhancement of intraparenchymal abducens nerve on MRI. Headache 2002, 42:140–144.

    Article  PubMed  Google Scholar 

  13. Burger SK, Saul RF, Selhorst JB, et al.: Transient monocular blindness caused by vasospasm. N Engl J Med 1991, 325:870–873.

    Article  PubMed  CAS  Google Scholar 

  14. Hupp SM, Kline LB, Corbett JJ: Visual disturbances of migraine. Surv Ophthalmol 1989, 33:221–236.

    Article  PubMed  CAS  Google Scholar 

  15. Flammer J, Pache M, Resink T: Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 2001, 20:319–349. Major comprehensive review of vasospastic ophthalmologic syndromes.

    Article  PubMed  CAS  Google Scholar 

  16. Dobbins KR, Saul RF: Transient visual loss after licorice ingestion. J Neuro-Ophthalmol 2000, 20:38–41.

    CAS  Google Scholar 

  17. Pietrobon D: Calcium channels and channelopathies of the central nervous system. Mol Neurobiol 2002, 25:31–50. Current reviews of genetic calcium channelopathies.

    Article  PubMed  CAS  Google Scholar 

  18. Goadsby PJ, Edvinsson L, Ekman R: Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990, 28:183–187.

    Article  PubMed  CAS  Google Scholar 

  19. May A, Goadsby PJ: The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999, 19:115–127.

    Article  PubMed  CAS  Google Scholar 

  20. Leao AA: Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944, 7:359–90.

    Google Scholar 

  21. Lauritzen M: Pathophysiology of the migraine aura: the spreading depression theory. Brain 1994, 117:199–210.

    Article  PubMed  Google Scholar 

  22. Woods RP, Iacoboni M, Mazziotta JC: Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994, 331:689–692.

    Article  Google Scholar 

  23. Boska MD, Welch KM, Barker PB, et al.: Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology 2002, 58:1227–1233.

    PubMed  CAS  Google Scholar 

  24. Mauskop A: Alternative therapies in headache. Is there a role? Med Clin North Am 2001, 85:1077–1084.

    Article  PubMed  CAS  Google Scholar 

  25. Mauskop A, Altura BT, Cracco RQ, et al.: Intravenous magnesium sulfate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Sci 1995, 89:633–636.

    PubMed  CAS  Google Scholar 

  26. Facchinetti F, Sances G, Borella P, et al.: Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991, 31:298–301.

    Article  PubMed  CAS  Google Scholar 

  27. Piekert A, Wilimzig C, Kohne-Volland R: Prophylaxis of migraine with oral magnesium: results from a prospective multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996, 16:257–263.

    Article  Google Scholar 

  28. Pfaffenrath V, Wessely P, Meyer C, et al.: Magnesium in the prophylaxis of migraine: a double-blind, placebo-controlled study. Cephalalgia 1996, 16:436–440.

    Article  PubMed  CAS  Google Scholar 

  29. Wang F, Van Den Eeden S, Ackerson L, et al.: Oral magnesium oxide prophylaxis of frequent childhood migraine [abstract]. Cephalalgia 2000, 20:424.

    Article  CAS  Google Scholar 

  30. Corbo J, Esses D, Bijur PE, et al.: Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med 2001, 38:621–627.

    Article  PubMed  CAS  Google Scholar 

  31. Harrah H, Shimazawa H, Hashimoto M, et al.: Anti-migraine effect of lomerizine. [abstract]. Nippon Yakurigaku Zasshi 1998, 112(suppl):138–142.

    Google Scholar 

  32. Toriu N, Sasaoka M, Shimazawa M, et al.: Effects of lomerizine, a novel Ca2+ channel blocker, on the normal and endothelin-1-disturbed circulation in the optic nerve lead of rabbits. J Ocul Pharmacol Ther 2001, 17:131–149.

    Article  PubMed  CAS  Google Scholar 

  33. Toriu N, Akinori A, Hiroki Y, et al.: Lomerizine, a Ca2+ channel blocker reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp Eye Res 2000, 70:475–484.

    Article  PubMed  CAS  Google Scholar 

  34. Fisher CM: Late-life (migrainous) scintillating zigzags without headache: one person’s 27-year experience. Headache 1999, 39:391–397.

    Article  PubMed  CAS  Google Scholar 

  35. Shah PA, Nafee A: Migraine aura masquerading as Balint’s syndrome. J Neurol Neurosurg Psychiatry 1999, 67:554–555.

    Article  PubMed  CAS  Google Scholar 

  36. Podoll K, Robinson D: Illusory splitting as visual aura symptom in migraine. Cephalgia 2000, 20:228–232.

    Article  CAS  Google Scholar 

  37. Podoll K, Robinson D: Recurrent lilliputian hallucinations as visual aura symptom in migraine. Cephalagia 2001, 21:990–992.

    Article  CAS  Google Scholar 

  38. Podoll K, Robinson D: Corona phenomena as visual aura symptom in migraine. Cephalalgia 2001, 21:712–717.

    Article  PubMed  CAS  Google Scholar 

  39. Lepore FE: The preserved temporal crescent: the clinical implications of an "endangered" finding. Neurology 2001, 57:1918–1921. Traditional "seasoned" neuro-ophthalmologists will find these articles refreshing and nostalgic.

    PubMed  CAS  Google Scholar 

  40. Sanin LC, Mathew NT: Severe diffuse intracranial vasospasm as a cause of extensive migrainous infarction. Cephalgia 1993, 13:298–292.

    Article  Google Scholar 

  41. Drier JP, Kleeberg J, Petzold G, et al.: Endothelin-1 potently induces Leao’s cortical spreading depression in vivo in the rat: a model for an endothelin-1 trigger of migrainous aura? Brain 2002, 125:102–112.

    Article  Google Scholar 

  42. Flammer J, Kaiser H, Haufschild T: Susac’s syndrome: a vasospastic disorder? Eur J Ophthamol 2001, 11:175–179.

    CAS  Google Scholar 

  43. Bowyer SM, Aurora KS, Moran JE, et al.: Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol 2001, 47:582–587.

    Article  Google Scholar 

  44. O’Brien MD: Cerebral blood changes in migraine. Headache 1971, 10:139–143.

    Article  PubMed  CAS  Google Scholar 

  45. Hadjikhani N, Sanchez del Rio M, Wu O, et al.: Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci 2001, 98:4687–4692. Important study.

    Article  PubMed  CAS  Google Scholar 

  46. Bolay H, Reuter U, Dunn AK, et al.: Intrinsic brain activity triggers trigeminal meningeal afferents in migraine model. Nat Med 2002, 8:136–142.

    Article  PubMed  CAS  Google Scholar 

  47. Senior K: New understanding into the mechanics of migraine. Lancet 2002, 359:500.

    Article  PubMed  Google Scholar 

  48. Mulleners WM, Chronicle EP, Vredeveld JW, et al.: Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS. Eur J Neurol 2002, 9:35–40.

    Article  PubMed  CAS  Google Scholar 

  49. Towne AR, Palinski KS, Garnett WR, et al.: Evaluation of topiramate in patients with transformed migraine headaches [abstract]. Neurology 2001, 56(suppl 3):A64-A65.

    Google Scholar 

  50. Roberson S, Hatfield R, Dixon B, et al.: Neuromodulation of late-life migrainous accompaniments with topiramate therapy [abstract]. Neurology 2001, 56(suppl 3):A64.

    Google Scholar 

  51. Chen WT, Fuh JL, Lu SR, et al.: Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache 2001, 41:823–825.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Virginia Commonwealth University, PO Box 980599, 23298-0599, Richmond, VA, USA

    Robert F. Saul MD

Authors
  1. Robert F. Saul MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saul, R.F. Ophthalmologic migraine. Curr Neurol Neurosci Rep 2, 432–435 (2002). https://doi.org/10.1007/s11910-002-0070-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-002-0070-x

Keywords

Search

Navigation